From genomic insights to clinical hope: Targeting NEU1 in IgA nephropathy

CONCLUSION: This study identifies NEU1 as a promising therapeutic target for IgAN, backed by robust genetic evidence. Future research should explore NEU1's therapeutic potential in diverse populations and clinical scenarios, further establishing its role in IgAN.PMID:38599098 | DOI:10.1016/j.intimp.2024.112051
Source: International Immunopharmacology - Category: Allergy & Immunology Authors: Source Type: research